title: Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats.
abstract: Recently μ opioid receptor (MOR) has been shown to be closely associated with depression. Here we investigated the action of Shuyu, a Chinese herbal prescription, on repeated restraint stress induced depression-like rats, with specific attention to the role of MOR and the related signal cascade. Our results showed that repeated restraint stress caused significant depressive-like behaviors, as evidenced by reduced body weight gain, prolonged duration of immobility in forced swimming test, and decreased number of square-crossings and rearings in open field test. The stress-induced depression-like behaviors were relieved by Shuyu, which was accompanied by decreased expression of MOR in hippocampus. Furthermore, Shuyu upregulated BDNF protein expression, restored the activity of CREB, and stimulated MEK and ERK phosphorylation in hippocampus of stressed rats. More importantly, MOR is involved in the effects of Shuyu on these depression-related signals, as they can be strengthened by MOR antagonist CTAP. Collectively, these data indicated that the antidepressant-like properties of Shuyu are associated with MOR and the corresponding CREB, BDNF, MEK, and ERK signal pathway. Our study supports clinical use of Shuyu as an effective treatment of depression and also suggests that MOR might be a target for treatment of depression and developing novel antidepressants.
authors.affiliation: Department of Pharmacology, College of Basic Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
authors.forename: Fu-Rong
authors.initials: FR
authors.lastname: Wang
authors.affiliation: Key Laboratory for Classical Theory of Traditional Chinese Medicine of Education Ministry, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
authors.forename: Ming-Qi
authors.initials: MQ
authors.lastname: Qiao
authors.affiliation: Key Laboratory for Classical Theory of Traditional Chinese Medicine of Education Ministry, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Xue
authors.affiliation: Key Laboratory for Classical Theory of Traditional Chinese Medicine of Education Ministry, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
authors.forename: Sheng
authors.initials: S
authors.lastname: Wei
references.citation: Pharmacol Biochem Behav. 2011 Oct;99(4):676-82
references.pmid: 21703297
references.citation: Am J Psychiatry. 2006 Jan;163(1):28-40
references.pmid: 16390886
references.citation: Arch Gen Psychiatry. 2006 Nov;63(11):1199-208
references.pmid: 17088500
references.citation: Neurosci Lett. 2011 Feb 4;489(2):131-5
references.pmid: 21145938
references.citation: J Pharmacol Sci. 2010;114(1):107-10
references.pmid: 20703010
references.citation: Neuropharmacology. 2010 Jan;58(1):241-7
references.pmid: 19596019
references.citation: Transl Psychiatry. 2014 Jul 15;4:e411
references.pmid: 25026323
references.citation: Int J Neuropsychopharmacol. 2013 Feb;16(1):151-62
references.pmid: 22217458
references.citation: Korean J Physiol Pharmacol. 2014 Jun;18(3):263-8
references.pmid: 24976767
references.citation: Neuropharmacology. 2009 Jan;56(1):37-46
references.pmid: 18657555
references.citation: Eur Neuropsychopharmacol. 2011 Dec;21(12):841-60
references.pmid: 21601431
references.citation: J Pharmacol Exp Ther. 2004 Sep;310(3):1020-6
references.pmid: 15121763
references.citation: Front Endocrinol (Lausanne). 2011 Aug 19;2(18):null
references.pmid: 22468144
references.citation: Eur J Pharmacol. 2008 Jan 28;579(1-3):116-25
references.pmid: 18028907
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):449-54
references.pmid: 16443316
references.citation: Neuropsychopharmacology. 2004 Aug;29(8):1512-21
references.pmid: 15199368
references.citation: Int J Neuropsychopharmacol. 2014 Jun;17(6):917-28
references.pmid: 24472498
references.citation: PLoS Med. 2006 Nov;3(11):e442
references.pmid: 17132052
references.citation: Am J Psychiatry. 2010 May;167(5):565-73
references.pmid: 20194481
references.citation: Phytother Res. 2013 Dec;27(12):1829-33
references.pmid: 23418105
references.citation: J Affect Disord. 2013 Sep 5;150(2):415-23
references.pmid: 23769609
references.citation: Front Neuroendocrinol. 2014 Jan;35(1):42-57
references.pmid: 24076484
references.citation: J Pharmacol Sci. 2012;120(3):176-86
references.pmid: 23076128
references.citation: J Microbiol Biotechnol. 2012 Mar;22(3):422-30
references.pmid: 22450800
references.citation: J Neurotrauma. 2013 Jul 15;30(14 ):1223-31
references.pmid: 23360216
references.citation: Synapse. 2004 Nov;54(2):72-82
references.pmid: 15352132
references.citation: Brain Res. 2003 Aug 8;980(2):191-6
references.pmid: 12867258
references.citation: Behav Brain Res. 2013 Apr 15;243:261-6
references.pmid: 23357086
references.citation: Exp Ther Med. 2013 Apr;5(4):1113-1116
references.pmid: 23599734
references.citation: Brain Res Bull. 2013 Oct;99:1-8
references.pmid: 24004471
references.citation: Exp Neurol. 2012 Apr;234(2):466-81
references.pmid: 22309829
references.citation: J Affect Disord. 2014 Jun;162:12-9
references.pmid: 24766998
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1623-30
references.pmid: 21749907
references.citation: Int J Neuropsychopharmacol. 2013 Jun;16(5):967-74
references.pmid: 23164431
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:143-50
references.pmid: 24370459